Bristol-Myers Squibb
BMY
#195
Rank
C$167.35 B
Marketcap
C$81.96
Share price
-1.61%
Change (1 day)
31.46%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): C$4.92

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$5.06. In 2025 the company made an earnings per share (EPS) of C$4.92 an increase over its 2024 EPS that were of C-$6.29.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.920.01%
2025C$4.92-178.28%
2024C-$6.29-213.92%
2023C$5.5230.2%
2022C$4.24-6.04%
2021C$4.51-179.29%
2020C-$5.69-281.37%
2019C$3.14-27.21%
2018C$4.31
2016C$3.80175.26%
2015C$1.38-19.83%
2014C$1.72-22.44%
2013C$2.2234.48%
2012C$1.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.43 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.98 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.92-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$40.15 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.60 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.64-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$13.30 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.06-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.89 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK